Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Fenwal International, Inc.
FDA Inspection
•Fenwal International, Inc.•September 18, 2024

Fenwal International, Inc. – FDA Inspection, Sep 18, 2024

Record Details

This FDA Inspection record concerns Fenwal International, Inc., with an inspection on September 18, 2024, issued by the San Juan District Office, covering biologics.

Company
Fenwal International, Inc.
Inspection Date
September 18, 2024
Product Type
Biologics
Office
San Juan District Office
People
  • Cody D. Rickman (FDA Associated Person)
  • Kody T Aikman (Issuing Officer)
  • Lisoida Perez (Issuing Officer)
  • Lizaida Perez (FDA Personnel)
  • Scott T. Ballard (FDA Associated Person)
View Company Profile

ID · bbfbf29d-dc82-49ba-ab37-9e43585cd00c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1250072
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued, view the record

FDA Citations

7
  1. 21 CFR 211.58Buildings not maintained in good state of repair
  2. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  3. 21 CFR 211.46(b)Equipment for Environmental Control
  4. 21 CFR 211.63Equipment Design, Size and Location
  5. 21 CFR 211.160(b)Scientifically sound laboratory controls
  6. 21 CFR 211.180(e)Records reviewed annually
  7. 21 CFR 211.52Washing and toilet facilities are deficient

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Fenwal International, Inc.

11
DateClassificationOfficeProject area
February 5, 2026Not classifiedSan Juan District OfficeBlood and Blood Products
September 24, 2022OAICenter for Biologics Evaluation and ResearchBlood and Blood Products
September 24, 2021OAICenter for Biologics Evaluation and ResearchBlood and Blood Products
September 26, 2019OAICenter for Biologics Evaluation and ResearchBlood and Blood Products
August 22, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 11 other inspections on the company page
Other documents for Fenwal International, Inc.
  • FDA Inspection 1294942 - 2026-02-05
  • FDA Inspection 1180297 - 2022-09-24
  • FDA Inspection 1152927 - 2021-09-24
  • FDA Inspection 1102938 - 2019-09-26
  • FDA Inspection 1022483 - 2017-08-22

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Fenwal International, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.